Rite Aid (RAD), Walgreen (WAG) Gain on Strong June Sales Results

Go back to Rite Aid (RAD), Walgreen (WAG) Gain on Strong June Sales Results

Goldman Sachs Comments on Rite-Aid (RAD) June Sales Data

July 3, 2014 10:38 AM EDT

Goldman Sachs maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $9.50. Comments follow June sales data. Analyst Robert P. Jones noted this was the strongest script comp since January 2013.

"RADs June SSS increased 3.9%, exceeding GS/consensus of 3.4%/2.8%, with script... More

Goldman Sachs Comments on Walgreen (WAG) June Sales Data

July 3, 2014 9:26 AM EDT

Goldman Sachs maintained a Conviction Buy on Walgreen (NYSE: WAG) with a price target of $84. Comments follow June sales data. Analyst Robert P. Jones noted that scripts continue to drive strong comps.

"WAG reported total June SSS of 7.5%,... More

Rite Aid (RAD) Front-End Comps Rose 0.9% in June

July 3, 2014 8:31 AM EDT

Rite Aid (NYSE: RAD) announced sales results for June.

Monthly Sales

For the four weeks ended June 28, 2014, same store sales increased 3.9 percent over the prior-year period. June front-end same store sales increased 0.9 percent. Pharmacy same store sales, which included an approximate 169 basis points negative impact... More

Walgreen (WAG) Comps Rose 7.5% in June

July 3, 2014 8:01 AM EDT

Walgreen Company (NYSE: WAG) had June sales of $6.28 billion, an increase of 8.9 percent from $5.77 billion for the same month in fiscal 2013.

Total front-end sales increased 1.8 percent in June compared with the same month in fiscal 2013, while comparable store front-end sales increased 1.3 percent. Customer traffic in comparable stores decreased 2.0 percent while basket size increased 3.3 percent.

Prescriptions filled at comparable stores increased by 7.3 percent in June and increased 4.7 percent on a calendar day-shift adjusted basis. June 2014 had one additional Monday and one fewer Saturday compared with June 2013. These... More